Identification of Candida dubliniensis based on temperature and utilization of xylose and α-methyl-D-glucoside as determined with the API 20C AUX and vitek YBC systems

被引:88
作者
Gales, AC
Pfaller, MA
Houston, AK
Joly, S
Sullivan, DJ
Coleman, DC
Soll, DR
机构
[1] Univ Iowa, Coll Med, Dept Pathol, Div Med Microbiol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA
[3] Univ Dublin Trinity Coll, Sch Dent Sci, Dept Oral Med & Pathol, Dublin 2, Ireland
[4] Univ Dublin Trinity Coll, Dublin Dental Hosp, Dublin 2, Ireland
[5] Univ Fed Sao Paulo, Dept Med, Div Infect Dis, Sao Paulo, Brazil
关键词
D O I
10.1128/JCM.37.12.3804-3808.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To have a better understanding of the role of Candida dubliniensis in clinical infections, it is essential that microbiology laboratories can identify this species rapidly and accurately in clinical specimens. C. dubliniensis has been reported to lack the ability to utilize xylose (XYL) and alpha-methyl-D-glucoside (MDG) and to grow poorly or not at all at 45 degrees C, whereas Candida albicans isolates utilize XYL and MDG and usually grow well at 45 degrees C. We tested 66 isolates of C. dubliniensis and 100 isolates of C. albicans with both the API 20C AUX and Vitek YBC systems to evaluate the ability of the XYL and MDG tests contained within each of these systems to distinguish between the two species. The ability to grow at 45 degrees C was also examined. None of the C. dubliniensis isolates grew at 45 degrees C, and 23 of 100 C. albicans isolates (23%) exhibited poor or no growth at 45 degrees C. The XYL and MDG tests contained,within the API 20C AUX system were both negative for all 66 C. dubliniensis isolates and were positive for 98 (XYL) and 56 (MDG) of the 100 C. albicans isolates. With the Vitek system, 64 of 66 C. dubliniensis isolates (97.0%) were XYL negative and 63 (95.0%) were MDG negative. Conversely, 96 of 100 C. albicans isolates (96.0%) were XYL positive and 100 (100.0%) were MDG positive with the Vitek system. Clinical microbiology laboratories could use lack of growth at 45 degrees C and a negative XYL test with either the API 20C AUX or Vitek yeast identification system to provide a presumptive identification of C. dubliniensis. A negative MDG test result with either system would also be helpful but may misclassify C. albicans as C. dubliniensis, especially when the API 20C AUX system is used.
引用
收藏
页码:3804 / 3808
页数:5
相关论文
共 24 条
[1]   Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C-dubliniensis blastospores and Candida albicans germ tubes [J].
Bikandi, J ;
San Millán, R ;
Moragues, MD ;
Cebas, G ;
Clarke, M ;
Coleman, DC ;
Sullivan, DJ ;
Quindós, G ;
Pontón, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (09) :2428-2433
[2]  
BUESCHING WJ, 1979, J CLIN MICROBIOL, V9, P565
[3]   Candidiasis: The emergence of a novel species, Candida dubliniensis [J].
Coleman, DC ;
Sullivan, DJ ;
Bennett, DE ;
Moran, GP ;
Barry, HJ ;
Shanley, DB .
AIDS, 1997, 11 (05) :557-567
[4]  
Coleman DC, 1998, MED MYCOL, V36, P156
[5]   Identification of Candida dubliniensis in a prospective study of patients in the United States [J].
Jabra-Rizk, MA ;
Baqui, AAMA ;
Kelley, JI ;
Falkler, WA ;
Merz, WG ;
Meiller, TF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (02) :321-326
[6]   Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis [J].
Joly, S ;
Pujol, C ;
Rysz, M ;
Vargas, K ;
Soll, DR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) :1035-1044
[7]   Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates [J].
Kirkpatrick, WR ;
Revankar, SG ;
McAtee, RK ;
Lopez-Ribot, JL ;
Fothergill, AW ;
McCarthy, DI ;
Sanche, SE ;
Cantu, RA ;
Rinaldi, MG ;
Patterson, TF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :3007-3012
[8]   Simple, reliable, and cost-effective yeast identification scheme for the clinical laboratory [J].
Koehler, AP ;
Chu, KC ;
Houang, ETS ;
Cheng, AFB .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (02) :422-426
[9]   Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation [J].
Meis, JFGM ;
Ruhnke, M ;
De Pauw, BE ;
Odds, FC ;
Siegert, W ;
Verweij, PE .
EMERGING INFECTIOUS DISEASES, 1999, 5 (01) :150-153
[10]   Fungal infections in patients with acquired immunodeficiency syndrome [J].
Minamoto, GY ;
Rosenberg, AS .
MEDICAL CLINICS OF NORTH AMERICA, 1997, 81 (02) :381-+